With biosim­i­lars gain­ing mo­men­tum, Am­gen and Al­ler­gan cite suc­cess of Her­cept­in's copy­cat

Am­gen and Al­ler­gan are re­port­ing a new suc­cess for their part­ner­ship aimed at de­vel­op­ing a slate of four big biosim­i­lars. In­ves­ti­ga­tors re­port­ed that ABP …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.